Walleye Trading
CNST

Walleye Trading’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Walleye Trading’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,700
Closed -$87K – 5758
2021
Q1 		$87K Sell
3,700
-3,400
-48% -$103K ﹤0.01% 4160
2020
Q4 		$204K Buy
+7,100
New +$179K ﹤0.01% 3507
2020
Q3 		– Sell
-8,800
Closed -$264K – 4849
2020
Q2 		$264K Buy
8,800
+300
+4% +$10.8K ﹤0.01% 2866
2020
Q1 		$267K Buy
+8,500
New +$296K ﹤0.01% 2378

Walleye Trading's CNST Position: Q3 2021 in Review

Walleye Trading sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 19,801 shares — an estimated $669K sold.

Walleye Trading first reported a position in CNST in Q1 2020 and held it in 3 quarters. The position peaked at $669K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Walleye Trading reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Walleye Trading sold 19,801 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $669K.
  • Walleye Trading first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
  • Walleye Trading's Constellation Pharmaceuticals, Inc. position peaked at $669K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.